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Abstract 
We report here the synthesis of a new 1,5-benzodiazepines derivatives by phase transfer catalysis. The structures of 
these products were investigated and confirmed by 
1
H, 
13
C NMR, mass spectroscopic and X-ray diffraction. 
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1. Introduction 
The benzodiazepine nucleus is a pharmacophoric scaffold and represents a class of heterocycles with a wide range of 
applications. These heterocyclic compounds are important constituents of biologically active products (Heterocyclic 
Chemistry 1998) and have attracted our considerable attention due to their applications such as pharmaceuticals and 
synthetic organic chemistry (Comprehensive Heterocyclic Chemistry 1996). In particular, several representative 
benzodiazepines possess significant biological activity as antimicrobial agents (Kumar et al.2007), antiviral ((a) 
Merluzzi et al. 1990 (b) Di Braccio et al. 2001), antitumor agents (Werner et al. 1990), analgesic (Di Brassio et al. 
1990), antipsychotic agents (Kavita et al. 1988), antifungal (Meerpoel et al. 2005), and may be considered support 
for the synthesis of more active heterocyclic systems. 
In this report, we describe practical protocol for the preparation of new 1,5-benzodiazepines via a C-alkylation by 
potassium tert-butoxide in tetrahydrofuran in a low temperature and an N-alkylation by sodium hydroxide in the 
presence of benzyltriethylammonium chloride in room temperature using the technical phase transfer catalysis (PTC). 
These new heterocyclic system can be susceptible to have pharmacological activity. This work is integrated in the 
development of our research series 1,4-(1,5)-benzodiazepines ((a) Benelbaghdadi et al. 2007 (b) Baouid et al. 2001 
(c) Boudina et al. 2006 ). 
 
2. Result and discussion 
In the first step, we have realized the N-alkylation of 4-phenyl-1H-1,5-benzodiazepin-2(3H)-one 1 with alkyl 
bromides moderately active secondary in the presence of 50% sodium hydroxide and 2% mol of 
benzyltriethylammonium chloride in benzene (Scheme 1).  
 
 
 
 
 
Scheme 1 
The compounds 2a-2f are obtained with excellent yields (Table 1). The structures of the products 2a-2f were 
determined by spectral data (mass, 
1
H, 
13
C NMR). Analysis, by the X-ray diffraction of compound 2d (Loughzail et 
al. 2011), was necessary to elucidate the stereochemistry of the power cycle benzodiazepine. 
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Table 1: N-Alkylation of 4-phenyl-1H-1,5-benzodiazepin-2(3H)-one 1 
Entry Products R-X Yield (%) 
1 2a CH3-I 90 
2 2b CH3(CH2)4-Br 94 
3 2c C6H5CH2-Br 92 
4 2d CHCCH2-Br 96 
5 2e CH2CHCH2-Br 92 
6 2f CH3CH2O2CCH2-Br 94 
 
Further, the action of N,N-dimethylformamide-dimethyl acetal (DMF-DMA) in 
4-phenyl-1H-1,5-benzodiazepin-2(3H)-one 1 at reflux leads to the formation of 
3-[(dimethylamino)methylidene]-4-phenyl-1H-1,5-benzodiazepin-2(3H)-one 3 with a good yield of 75% (Scheme 2). 
Its structure is identified by mass spectral data and NMR (
1
H, 
13
C, mass) and the stereochemistry is determined by 
X-ray diffraction (Figure 1). 
 
 
 
 
 
Scheme 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Ortep of (E)-3-[(dimethylamino)methylidene]-4-phenyl-1H-1,5-benzodiazepin-2(3H)-one 3 
 
The asymmetric unit of the compound 3 consists of two independent molecules, each having an (E) configuration 
with respect to the C=C bond between the benzodiazepinone and dimethylamine groups. In the crystal, the two 
independent molecules are linked into a dimer by a pair of N—H….O hydrogen bonds. 
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In the second step, we performed the synthesis of compounds 4a-4f by two synthetic routes using method A 
(DMF-DMA/reflux) and method B (RX/PTC) (Scheme 3). Therefore, we adopted the method as A practical protocol 
for the synthesis of 4a-4f because it leads to better yields (Table 2). The structures of compounds 4a-4f are 
determined from mass spectral data and 
1
H, 
13
C NMR. The analysis by X-ray diffraction of product 4d (Loughzail et 
al. 2014, Figure 2) confirms the structure and stereochemistry of the heterocyclic system. 
 
 
 
 
 
 
Scheme 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Ortep of (E)-3-[(dimethylamino)methylidene]-4-phenyl-1-(prop-2-ynyl)-1H-1,5-benzodiazepin-2(3H)-one 
4d 
 
 
The 3-[(dimethylamino)methylidene]-4-phenyl-1-(prop-2-ynyl)-1H-1,5-benzodiazepin-2(3H)-one 4d, exhibits an (E) 
configuration with respect to the C=C bond between the benzodiazepine and dimethylamine groups. The 
seven-membered diazepine ring displays a boat conformation. In the crystal, molecules are linked by a C—H….O 
hydrogen bond, forming a chain along [110]. 
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Table 2: Synthesis of 1-alkyl-3-dimethylaminomethylidene-4-phenyl-1H-1,5-benzodiazepin-2(3H)-one 4 
Entry Products Structures 
Yield (%) 
Method A Method B 
1 4a 
N
N
C6H5
O
H3C
N
CH3
CH3
 
80 62 
2 4b 
N
N
C6H5
O
N
CH3
CH3
 
68 46 
3 4c 
N
N
C6H5
O
N
CH3
CH3
C6H5  
82 63 
4 4d 
N
N
C6H5
O
N
CH3
CH3
 
93 70 
5 4e 
N
N
C6H5
O
N
CH3
CH3
 
92 68 
6 4f N
N
C6H5
O
N
CH3
CH3
EtO
O
 
88 64 
All reactions were carried out under optimization conditions. 
Method A: DMF-DMA, refluxed at 100°C for 4 h. 
Method B: RX, 50% NaOH, 2% ClBzEt3N (PTC). 
 
3. Conclusion 
In summary, we have developed an efficient method for the synthesis of enamino benzodiazepines derivatives. The 
advantages the presented methodology are efficiency, simplicity, high yield, cleaner reaction profile, easy product 
isolation, and finally an attractive strategy for the preparation of enamino benzodiazepines compounds.  
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Experimental Section 
General 
Melting points were taken in an open capillary tube on a Buchi 510 apparatus and are uncorrected. Spectra were 
recorded with the following instruments: 1H NMR spectra: Brüker AC-300, 13C NMR spectra: Brüker AC-75, Mass 
spectra: Jeol JMS DX 300. TMS was used as an internal reference. Column chromatography was carried out using 
E-Merck silica gel 60F254. Reagents and solvents were purified in the usual way. 
 
General procedure for preparation of 1-alkyl-4-phenyl-1H-1,5-benzodiazepin-2(3H)-one 2a-2f 
A mixture of 1 g (4.6 mmol) of 4-phenyl-1H-1,5-benzodiazepin-2(3H)-one 1, 0.43 g (2.3 mmol) of 
benzyltriethylammonium chloride and 3 mL of a 50% sodium hydroxide aqueous solution in benzene (25 mL) was 
stirred at ambient temperature. After 15 min, alkyl bromide was added slowly. After 6 h of stirring at 298 K, the 
reaction mixture was diluted with water (30 mL). The organic layer was extracted with benzene (3 × 10 mL), dried 
over anhydrous sodium sulfate and evaporated under vacuum. The title compound was isolated by column 
chromatography on silica gel using hexane/ethyl acetate as eluent. The solid product was recrystallized in 
dichloromethane to give of 2a-2f. 
2a Yield 90%. Melting point: 347–349 K. 1H NMR (300 MHz, CDCl3): δ 3.23 (s, 3H, N-CH3), 2.81 and 4.00 (AB 
system, d, J= 11.7 Hz, 2H, CH2), 7.11-8.04 (9H, Ar-H).
13
C NMR (75 MHz, CDCl3): δ 35.2 (1C, N-CH3), 40.1 (1C, 
CH2), 121.9 - 141.9 (12C, Ar-C), 165.1 (1C, Ph-C=N), 166.7 (1C, CO). MS (EI, m/z): 251[M+H]
+
. 
 
2b Yield 94%. Melting point: 352–354 K. 1H NMR (300 MHz, CDCl3): δ 0.76 (t, J= 7.2 Hz, 3H, CH3), 3.02 and 4.17 
(AB system, d, J= 12 Hz, 2H, CH2-CO-N), 7.26-8.04 (9H, Ar-H). 
13
C NMR (75 MHz, CDCl3): δ 13.6 (1C, CH3), 
19.8, 30.0, 30.1, 46.9 (4C, CH2), 40.1 (1C, CH2-CO-N), 122.4 - 131.1 (12C, Ar-C), 165.1 (1C, Ph-C=N), 166.4 (1C, 
CO). MS (EI, m/z): 307 [M+H]
+
. 
 
2c Yield 92%. Melting point: 401–403 K. 1H NMR (300 MHz, CDCl3): δ 3.15 and 4.22 (AB system, d, J= 11.7 Hz, 
2H, CH2-CO-N), 5.14 (s, 2H, N-CH2), 7.07-8.04 (14H, Ar-H). 
13
C NMR (75 MHz, CDCl3): δ 40.0 (1C, CH2), 51.2 
(1C, N-CH2), 122.4-141.7 (18C, Ar-C), 165.1 (1C, Ph-C=N), 166.4 (1C, CO). MS (EI, m/z): 327 [M+H]
+
. 
 
2d Yield 96%. Melting point: 438–440 K. 1H NMR (300 MHz, CDCl3): δ 2.32 (t, J= 2.25 Hz, 1H, HC≡C), 3.04 and 
4.76 (AB system, d, J=12 Hz, 2H, CH2-CO-N), 4.19 and 4.27 (AB system, d, J= 17.7 Hz, 2H, N-CH2-C), 7.25-8.14 
(9H, Ar-H).
13
C NMR (75 MHz, CDCl3): δ 36.9 (1C, N-CH2-C), 39.1 (1C, CH2-CO-N), 71.9 (1C, HC≡C), 78.5 (1C, 
HC≡ C), 120.9-140.9 (12C, Ar-C), 160.0 (1C, Ph-C=N), 165.0 (1C, CO). MS (EI, m/z): 275 [M+H]+. 
 
2e Yield 92%. Melting point: 432–434 K. 1H NMR (300 MHz, CDCl3): δ 3.35 and 4.82 (AB system, d, J=12.15 Hz, 
2H, CH2-CO-N), 4.50 (m, 2H, N-CH2), 5.15 (m, 2H, CH2=CH), 5.85 (m, 1H, CH2=CH), 7.25-8.14 (9H, Ar-H).
13
C 
NMR (75 MHz, CDCl3): δ 44.53 (1C, CH2-CO-N), 50.57 (N-CH2), 117.56 (CH2=C), 123.32 (C=CH), 120.9-140.9 
(12C, Ar-C), 165.1 (1C, Ph-C=N), 166.4 (1C, CO). MS (EI, m/z): 277 [M+H]
+
.
 
 
2f Yield 94%. Melting point: 418–420 K. 1H NMR (300 MHz, CDCl3): δ 1.23 (t, J= 7.2 Hz, 3H, CH3), 3.12 and 4.22 
(AB system, d, J= 12 Hz, 2H, N-CH2), 4.17 and 4.63 (AB system, d, J= 17.1 Hz, 2H, CH2-CO), 4.24 (q, J= 7.2 Hz, 
2H, CH2), 7.26-8.14 (9H, Ar-H).
13
C NMR (75 MHz, CDCl3): δ 14.1 (1C, CH3), 39.5, 50.6, 61.7 (3C, CH2), 
121.9-141.8 (12C, Ar-C), 166.2 (1C, Ph-C=N), 168.8 (1C, N-CO), 196.2 (1C, CO). MS (EI, m/z): 295 [M+H]
+
. 
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Synthesis of (E)-3-dimethylaminomethylene-4-phenyl-1H-1,5-benzodiazepin-2(3H)-one 3 
A mixture of 0.47 g (1.98 mmol) of 4-phenyl-1H-1,5-benzodiazepin-2(3H)-one 1 in 4.5 mL of 
dimethylformamide-dimethylacetal (DMF-DMA) was stirred at 100°C for 4 hours and then cooled to ambient 
temperature. Filtration and washing with a little cold diethyl ether gave 0.46 g of 
3-dimethylaminomethylidene-4-phenyl-1H-1,5-benzodiazepin-2(3H)-one 3. The product obtained was recrystallized 
from diethyl ether.  
3 Yield: 75%. Melting point: 497-498 K. 
1
H NMR (CDCl3, 300 MHz): δ 2.55 (s, 6H, (CH3)2N), 2.80 (s, 1H, NH), 
6.32 (s, 1H, C=CH-N), 7.04-7.92 (m, 9H, H-Ar). 
13
C NMR (CDCl3, 75 MHz): δ 43.50 (N(CH3)2), 98.02 (C=), 
121.47-141.86 (12C-Ar), 151.18 (CH-N(CH3)2), 167.40 (Ph-C=N), 178.57 (CO). MS (m/z, %): 292 ([M+H]
+
. 
 
Preparation of 1-alkyl-3-dimethylaminomethylidene-4-phenyl-1H-1,5-benzodiazepin-2(3H)-one 4a-4f 
 
Method A: A mixture of 0.6 g (2.06 mmol) of 3-dimethylaminomethylidene-4-phenyl-1H-1,5-benzo- 
diazepin-2(3H)-one 3, 0.1 g (1.03 mmol) of benzyltriethylammonium chloride and 3 mL of a 50% sodium hydroxide 
aqueous solution in benzene (25 mL) was stirred at ambient temperature. After 15 min, alkyl bromide was added 
slowly. After 8 h of stirring at 298 K, the reaction mixture was diluted with water (30 mL). The organic layer was 
extracted with benzene (3 × 10 mL), dried over anhydrous sodium sulfate and evaporated under vacuum. The title 
compound was isolated by column chromatography on silica gel using hexane/ethyl acetate as eluent. The solid 
product was recrystallized in dichloromethane to give 4a-4f. 
 
Method B: A mixture of 0.50 g of 1-alkyl-4-phenyl-1H-1,5-benzodiazepin-2(3H)-one 2a-2f in 4.5 mL of 
DMF-DMA was stirred at 100°C for 4 hours and then cooled to ambient temperature. Filtration and washing with a 
little cold diethyl ether gave 1-alkyl-3-dimethylaminomethylidene-4-phenyl-1H-1,5-benzo- diazepin-2(3H)-one 
4a-4f. The product obtained was recrystallized from diethyl ether.  
 
4a Yield 80%. Melting point: 473–477 K. 1H NMR (300 MHz, CDCl3): δ 2.58 (s, 6H, (CH3)2N), 3.28 (s, 3H, NCH3), 
6.32 (s, 1H, C=CH-N), 7.16-8.02 (9H, H-Ar). 
13
C NMR (CDCl3, 75 MHz): δ 35.5 (NCH3), 42.8 (N(CH3)2), 98.3 
(C=), 120.9-150.2 (12C-Ar, N-CH=), 176.3 (CO). MS (m/z, %): 306 ([M+H]
+
. 
 
4b Yield 68%. Melting point: 479–481 K. 1H NMR (300 MHz, CDCl3): δ 0.82 (t, J= 7.2 Hz, 3H, CH3), 2.64 (s, 6H, 
(CH3)2N), 6.22 (s, 1H, C=CH-N), 7.16-8.02 (9H, H-Ar). 
13
C NMR (CDCl3, 75 MHz): δ 13.6 (1C, CH3), 19.9, 30.3, 
30.4, 47.1 (4C, CH2), 42.8 (N(CH3)2), 98.3 (C=), 120.9-150.2 (C-Ar, N-CH), 165.1 (1C, Ph-C=N), 176.6 (CO). MS 
(m/z, %): 362 ([M+H]
+
. 
 
4c Yield 82%. Melting point: 484–486 K. 1H NMR (300 MHz, CDCl3): δ 2.58 (s, 6H, (CH3)2N), 4.81 and 5.30 (AB 
system, d, J= 15Hz, 2H, CH2-N), 6.46 (s, 1H, C=CH-N), 7.01-7.93 (14H, H-Ar). 
13
C NMR (CDCl3, 75 MHz): δ 42.6 
(N(CH3)2), 49.0 (1C, N-CH2), 97.4 (C=), 136.6-145.9 (C-Ar, =CH), 165.5 (1C, Ph-C=N), 173.9 (CO). MS 
(m/z, %): 382 ([M+H]
+
. 
 
4d Yield 93%. Melting point: 488–490 K. 1H NMR (300 MHz, CDCl3): δ 2.36 (t, J= 2.27 Hz, 1H, HC≡C), 2.58 (s, 
6H, (CH3)2N), 4.21 and 4.29 (AB system, d, J= 17.9 Hz, 2H, N-CH2-C), 6.46 (s, 1H, C=CH-N),7.15-8.11 (9H, 
Ar-H).
13
C NMR (75 MHz, CDCl3): δ 37.1 (1C, N-CH2-C), 42.6 (N(CH3)2), 71.9 (1C, HC≡C), 78.5 (1C, HC≡ C), 
97.8 (C=), 120.9-140.9 (Ar-C, =CH), 164.8 (1C, Ph-C=N), 169 (1C, CO). MS (EI, m/z): 330 [M+H]
+
.  
 
Chemistry and Materials Research                                                                          www.iiste.org 
ISSN 2224- 3224 (Print) ISSN 2225- 0956 (Online) 
Vol.6 No.1, 2014 
 
99 
4e Yield 92%. Melting point: 480–482 K. 1H NMR (300 MHz, CDCl3): δ 2.79 (s, 6H, (CH3)2N), 4.42 (m, 2H, 
N-CH2), 5.14 (m, 2H, CH2=CH), 5.83 (m, 1H, CH2=CH), 6.36 (s, 1H, C=CH-N), 7.1-8.02 (9H, H-Ar).
13
C NMR 
(CDCl3, 75 MHz): δ 42.8 (N(CH3)2), 50.0 (1C, N-CH2), 98.4 (C=), 116.7 (CH2=C), 116.6-149.9 (C-Ar, =CH, N-CH), 
165.7 (1C, Ph-C=N), 172.9 (CO). MS (m/z, %): 332 ([M+H]
+
. 
 
4f Yield 88%. Melting point: 460–462 K. 1H NMR (300 MHz, CDCl3): δ 1.19 (t, J= 7.2 Hz, 3H, CH3), 2.79 (s, 6H, 
(CH3)2N), 3.95 and 4.58 (AB system, d, J= 17.1 Hz, 2H, CH2-CO),4.21 (q, J= 7.2 Hz, 2H, CH2), 6.32 (s, 1H, 
C=CH-N), 7.04-7.92 (9H, H-Ar). 
13
C NMR (CDCl3, 75 MHz): δ 14.1 (1C, CH3), 42.8 (N(CH3)2), 51.1 (1C, O-CH2), 
61.2 (1C, N-CH2), 98.0 (C=), 121.5-150.2 (C-Ar, N-CH), 165.7 (1C, Ph-C=N), 169.9 (CO), 175.1 (O-CO). MS 
(m/z, %): 378 ([M+H]
+
. 
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